- Home
- ZG vs TEVA Comparison
ZG vs TEVA Comparison
Compare ZG & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZG
- TEVA
- Stock Information
- Founded
- ZG 2004
- TEVA 1901
- Country
- ZG United States
- TEVA Israel
- Employees
- ZG N/A
- TEVA N/A
- Industry
- ZG Business Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- ZG Consumer Discretionary
- TEVA Health Care
- Exchange
- ZG Nasdaq
- TEVA Nasdaq
- Market Cap
- ZG 17.6B
- TEVA 18.4B
- IPO Year
- ZG 2011
- TEVA N/A
- Fundamental
- Price
- ZG $61.49
- TEVA $13.65
- Analyst Decision
- ZG Buy
- TEVA Strong Buy
- Analyst Count
- ZG 26
- TEVA 6
- Target Price
- ZG $80.68
- TEVA $24.00
- AVG Volume (30 Days)
- ZG 598.5K
- TEVA 12.0M
- Earning Date
- ZG 05-07-2025
- TEVA 05-07-2025
- Dividend Yield
- ZG N/A
- TEVA N/A
- EPS Growth
- ZG N/A
- TEVA N/A
- EPS
- ZG N/A
- TEVA N/A
- Revenue
- ZG $2,236,000,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- ZG $16.41
- TEVA $5.31
- Revenue Next Year
- ZG $14.83
- TEVA $1.18
- P/E Ratio
- ZG N/A
- TEVA N/A
- Revenue Growth
- ZG 14.96
- TEVA 4.41
- 52 Week Low
- ZG $38.06
- TEVA $12.47
- 52 Week High
- ZG $86.58
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- ZG 40.11
- TEVA 37.96
- Support Level
- ZG $60.27
- TEVA $13.24
- Resistance Level
- ZG $63.42
- TEVA $13.83
- Average True Range (ATR)
- ZG 3.42
- TEVA 0.80
- MACD
- ZG -0.16
- TEVA -0.03
- Stochastic Oscillator
- ZG 35.47
- TEVA 38.44
About ZG Zillow Group Inc.
Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Premier Agent and others.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.